Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients

PloS One
Julia DietzChristoph Sarrazin

Abstract

Different highly effective interferon-free treatment options for chronic hepatitis C virus (HCV) infection are currently available. Pre-existence of resistance associated variants (RAVs) to direct antiviral agents (DAAs) reduces sustained virologic response (SVR) rates by 3-53% in hepatitis C virus (HCV) genotype 1 infected patients depending on different predictors and the DAA regimen used. Frequencies of single and combined resistance to NS3, NS5A and NS5B inhibitors and consequences for the applicability of different treatment regimens are unknown. Parallel population based sequencing of HCV NS3, NS5A and NS5B genes in 312 treatment-naïve Caucasian HCV genotype 1 infected patients showed the presence of major resistant variants in 20.5% (NS3), 11.9% (NS5A), and 22.1% (NS5B) with important differences for HCV subtypes. In NS3, Q80K was observed in 34.7% and 2.1% of subtype 1a and 1b patients, respectively while other RAVs to second generation protease inhibitors were detected rarely (1.4%). Within NS5A RAVs were observed in 7.1% of subtype 1a and 17.6% in subtype 1b infected patients. RAVs to non-nucleoside NS5B inhibitors were observed in 3.5% and 44.4% of subtype 1a and 1b patients, respectively. Considering all three DAA t...Continue Reading

References

Nov 26, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas KuntzenTodd M Allen
Mar 6, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Silvana GaudieriMichaela Lucas
Feb 24, 2010·Antimicrobial Agents and Chemotherapy·Oliver LenzKenneth A Simmen
Jun 30, 2010·Antimicrobial Agents and Chemotherapy·Robert A FridellMin Gao
Aug 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert A FridellMin Gao
Feb 4, 2012·Journal of Hepatology·Christoph SarrazinJean-Michel Pawlotsky
Apr 18, 2012·Antimicrobial Agents and Chemotherapy·Fiona McPheeClaudio Pasquinelli
Jun 5, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Fumitaka SuzukiHiromitsu Kumada
Dec 4, 2012·Best Practice & Research. Clinical Gastroenterology·Johannes Vermehren, Christoph Sarrazin
Jan 4, 2013·The New England Journal of Medicine·Fred PoordadBarry Bernstein
Mar 19, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fiona McPheeDavid Gardiner
Apr 24, 2013·The New England Journal of Medicine·Eric LawitzEdward J Gane
Jun 12, 2013·Nature Reviews. Microbiology·Ralf BartenschlagerFrancois Penin
Aug 16, 2013·The New England Journal of Medicine·Eric Lawitz, Edward J Gane
Aug 16, 2013·The New England Journal of Medicine·Ching-Sheng Hsu
Jan 10, 2014·Journal of Medicinal Chemistry·David A DeGoeyWarren M Kati
Jan 17, 2014·The New England Journal of Medicine·Mark S SulkowskiUNKNOWN AI444040 Study Group
Mar 4, 2014·Antiviral Research·Maximilian David Schneider, Christoph Sarrazin
Apr 12, 2014·The New England Journal of Medicine·Stefan ZeuzemBarry Bernstein
Apr 12, 2014·The New England Journal of Medicine·Kris V KowdleyUNKNOWN ION-3 Investigators
Apr 12, 2014·The New England Journal of Medicine·Jordan J FeldBarry Bernstein
Apr 15, 2014·The New England Journal of Medicine·Fred PoordadBarry Bernstein
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-2 Investigators
Apr 15, 2014·The New England Journal of Medicine·Nezam AfdhalUNKNOWN ION-1 Investigators
May 6, 2014·The New England Journal of Medicine·Peter FerenciUNKNOWN PEARL-IV Study
May 6, 2014·The New England Journal of Medicine·Stefan ZeuzemUNKNOWN VALENCE Investigators
Aug 15, 2014·Current Opinion in Pharmacology·Andrea De LucaBarbara Rossetti
Aug 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Eric F DonaldsonLisa K Naeger
Oct 1, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Evguenia S SvarovskaiaHongmei Mo
Dec 3, 2014·Antimicrobial Agents and Chemotherapy·Tami Pilot-MatiasChristine Collins
Dec 3, 2014·Antimicrobial Agents and Chemotherapy·Preethi KrishnanTami Pilot-Matias
Dec 24, 2014·Antimicrobial Agents and Chemotherapy·Warren KatiChristine Collins
Jan 24, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David R NelsonUNKNOWN ALLY-3 Study Team
Nov 26, 2015·The Journal of Infectious Diseases·Evguenia S SvarovskaiaHongmei Mo

❮ Previous
Next ❯

Citations

Oct 20, 2015·Protein Expression and Purification·Thomas SoranzoJean-Luc Lenormand
Jul 13, 2016·Reviews in Medical Virology·Lize CuypersJürgen Kurt Rockstroh
Jul 8, 2016·Expert Opinion on Drug Metabolism & Toxicology·Isabella EspositoVicente Soriano
Jan 31, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Christophe HézodeStefan Zeuzem
Nov 21, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chetan KalalSamir Shah
Mar 30, 2018·Expert Opinion on Pharmacotherapy·P de Leuw, C Stephan
Nov 1, 2016·Clinical Microbiology Reviews·Eleanor M WilsonShyam Kottilil
Aug 21, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Slim FouratiJean-Michel Pawlotsky
Jan 14, 2018·Digestive Diseases and Sciences·Enass A Abdel-HameedKenneth E Sherman
Jul 9, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Julia DietzUNKNOWN European HCV Resistance Study Group
May 6, 2016·Expert Opinion on Pharmacotherapy·Laura Benítez-GutiérrezVicente Soriano
Nov 12, 2016·World Journal of Gastroenterology : WJG·Dimas Alexandre KliemannCharles Wood
May 6, 2020·PloS One·Felix PiechaJulian Schulze Zur Wiesch
Oct 13, 2018·World Journal of Hepatology·Heidar Sharafi, Seyed Moayed Alavian
Apr 26, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Heidar SharafiSeyed Moayed Alavian
May 3, 2019·Journal of Clinical Microbiology·Kai-Henrik PeifferChristoph Sarrazin
Sep 10, 2020·Virusdisease·Ana Elisa de Figueiredo Miranda MundimAntonio Márcio Teodoro Cordeiro Silva
Nov 5, 2019·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Zhenqiu LiuXingdong Chen
Jun 5, 2021·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Miłosz ParczewskiJerzy Jaroszewicz

❮ Previous
Next ❯

Methods Mentioned

BETA
PCRs
PCR

Software Mentioned

BioEdit

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.